Machine learning methods are increasingly applied in medical imaging, yet many reported improvements lack statistical robustness: recent works have highlighted that small but significant performance gains are highly likely to be false positives. However, these analyses do not take \emph{underspecification} into account -- the fact that models achieving similar validation scores may behave differently on unseen data due to random initialization or training dynamics. Here, we extend a recent statistical framework modeling false outperformance claims to include underspecification as an additional variance component. Our simulations demonstrate that even modest seed variability ($\sim1\%$) substantially increases the evidence required to support superiority claims. Our findings underscore the need for explicit modeling of training variance when validating medical imaging systems.

In this study, we present an interpretable deep learning framework for the early detection of breast cancer using quantitative features extracted from digitized fine needle aspirate (FNA) images of breast masses. Our deep neural network, using ReLU activations, the Adam optimizer, and a binary cross-entropy loss, delivers state-of-the-art classification performance, achieving an accuracy of 0.992, precision of 1.000, recall of 0.977, and an F1 score of 0.988. These results substantially exceed the benchmarks reported in the literature. We evaluated the model under identical protocols against a suite of well-established algorithms (logistic regression, decision trees, random forests, stochastic gradient descent, K-nearest neighbors, and XGBoost) and found the deep model consistently superior on the same metrics. Recognizing that high predictive accuracy alone is insufficient for clinical adoption due to the black-box nature of deep learning models, we incorporated model-agnostic Explainable AI techniques such as SHAP and LIME to produce feature-level attributions and human-readable visualizations. These explanations quantify the contribution of each feature to individual predictions, support error analysis, and increase clinician trust, thus bridging the gap between performance and interpretability for real-world clinical use. The concave points feature of the cell nuclei is found to be the most influential feature positively impacting the classification task. This insight can be very helpful in improving the diagnosis and treatment of breast cancer by highlighting the key characteristics of breast tumor.

Lung cancer, a malignancy originating in lung tissues, is commonly diagnosed and classified using medical imaging techniques, particularly computed tomography (CT). Despite the integration of machine learning and deep learning methods, the predictive efficacy of automated systems for lung cancer classification from CT images remains below the desired threshold for clinical adoption. Existing research predominantly focuses on binary classification, distinguishing between malignant and benign lung nodules. In this study, a novel deep learning-based approach is introduced, aimed at an improved multi-class classification, discerning various subtypes of lung cancer from CT images. Leveraging a pre-trained ResNet model, lung tissue images were classified into three distinct classes, two of which denote malignancy and one benign. Employing a dataset comprising 15,000 lung CT images sourced from the LC25000 histopathological images, the ResNet50 model was trained on 10,200 images, validated on 2,550 images, and tested on the remaining 2,250 images. Through the incorporation of custom layers atop the ResNet architecture and meticulous hyperparameter fine-tuning, a remarkable test accuracy of 98.8% was recorded. This represents a notable enhancement over the performance of prior models on the same dataset.

Mammography, the current standard for breast cancer screening, has reduced sensitivity in women with dense breast tissue, contributing to missed or delayed diagnoses. Thermalytix, an AI-based thermal imaging modality, captures functional vascular and metabolic cues that may complement mammographic structural data. This study investigates whether a breast density-informed multi-modal AI framework can improve cancer detection by dynamically selecting the appropriate imaging modality based on breast tissue composition. A total of 324 women underwent both mammography and thermal imaging. Mammography images were analyzed using a multi-view deep learning model, while Thermalytix assessed thermal images through vascular and thermal radiomics. The proposed framework utilized Mammography AI for fatty breasts and Thermalytix AI for dense breasts, optimizing predictions based on tissue type. This multi-modal AI framework achieved a sensitivity of 94.55% (95% CI: 88.54-100) and specificity of 79.93% (95% CI: 75.14-84.71), outperforming standalone mammography AI (sensitivity 81.82%, specificity 86.25%) and Thermalytix AI (sensitivity 92.73%, specificity 75.46%). Importantly, the sensitivity of Mammography dropped significantly in dense breasts (67.86%) versus fatty breasts (96.30%), whereas Thermalytix AI maintained high and consistent sensitivity in both (92.59% and 92.86%, respectively). This demonstrates that a density-informed multi-modal AI framework can overcome key limitations of unimodal screening and deliver high performance across diverse breast compositions. The proposed framework is interpretable, low-cost, and easily deployable, offering a practical path to improving breast cancer screening outcomes in both high-resource and resource-limited settings.

Self-supervised learning (SSL) has transformed vision encoder training in general domains but remains underutilized in medical imaging due to limited data and domain specific biases. We present MammoDINO, a novel SSL framework for mammography, pretrained on 1.4 million mammographic images. To capture clinically meaningful features, we introduce a breast tissue aware data augmentation sampler for both image-level and patch-level supervision and a cross-slice contrastive learning objective that leverages 3D digital breast tomosynthesis (DBT) structure into 2D pretraining. MammoDINO achieves state-of-the-art performance on multiple breast cancer screening tasks and generalizes well across five benchmark datasets. It offers a scalable, annotation-free foundation for multipurpose computer-aided diagnosis (CAD) tools for mammogram, helping reduce radiologists' workload and improve diagnostic efficiency in breast cancer screening.

Aims Late diagnosis of Oral Squamous Cell Carcinoma (OSCC) contributes significantly to its high global mortality rate, with over 50\% of cases detected at advanced stages and a 5-year survival rate below 50\% according to WHO statistics. This study aims to improve early detection of OSCC by developing a multimodal deep learning framework that integrates clinical, radiological, and histopathological images using a weighted ensemble of DenseNet-121 convolutional neural networks (CNNs). Material and Methods A retrospective study was conducted using publicly available datasets representing three distinct medical imaging modalities. Each modality-specific dataset was used to train a DenseNet-121 CNN via transfer learning. Augmentation and modality-specific preprocessing were applied to increase robustness. Predictions were fused using a validation-weighted ensemble strategy. Evaluation was performed using accuracy, precision, recall, F1-score. Results High validation accuracy was achieved for radiological (100\%) and histopathological (95.12\%) modalities, with clinical images performing lower (63.10\%) due to visual heterogeneity. The ensemble model demonstrated improved diagnostic robustness with an overall accuracy of 84.58\% on a multimodal validation dataset of 55 samples. Conclusion The multimodal ensemble framework bridges gaps in the current diagnostic workflow by offering a non-invasive, AI-assisted triage tool that enhances early identification of high-risk lesions. It supports clinicians in decision-making, aligning with global oncology guidelines to reduce diagnostic delays and improve patient outcomes.

Abstract--Lung cancer continues to be the predominant cause of cancer-related mortality globally. This review analyzes various approaches, including advanced image processing methods, focusing on their efficacy in interpreting CT scans, chest radiographs, and biological markers. Notably, we identify critical gaps in the previous surveys, including the need for robust models that can generalize across diverse populations and imaging modalities. This comprehensive synthesis aims to serve as a foundational resource for researchers and clinicians, guiding future efforts toward more accurate and efficient lung cancer detection. Key findings reveal that 3D CNN architectures integrated with CT scans achieve the most superior performances, yet challenges such as high false positives, dataset variability, and computational complexity persist across modalities.

This study investigates the effectiveness of U-Net architectures integrated with various convolutional neural network (CNN) backbones for automated lung cancer detection and segmentation in chest CT images, addressing the critical need for accurate diagnostic tools in clinical settings. A balanced dataset of 832 chest CT images (416 cancerous and 416 non-cancerous) was preprocessed using Contrast Limited Adaptive Histogram Equalization (CLAHE) and resized to 128x128 pixels. U-Net models were developed with three CNN backbones: ResNet50, VGG16, and Xception, to segment lung regions. After segmentation, CNN-based classifiers and hybrid models combining CNN feature extraction with traditional machine learning classifiers (Support Vector Machine, Random Forest, and Gradient Boosting) were evaluated using 5-fold cross-validation. Metrics included accuracy, precision, recall, F1-score, Dice coefficient, and ROC-AUC. U-Net with ResNet50 achieved the best performance for cancerous lungs (Dice: 0.9495, Accuracy: 0.9735), while U-Net with VGG16 performed best for non-cancerous segmentation (Dice: 0.9532, Accuracy: 0.9513). For classification, the CNN model using U-Net with Xception achieved 99.1 percent accuracy, 99.74 percent recall, and 99.42 percent F1-score. The hybrid CNN-SVM-Xception model achieved 96.7 percent accuracy and 97.88 percent F1-score. Compared to prior methods, our framework consistently outperformed existing models. In conclusion, combining U-Net with advanced CNN backbones provides a powerful method for both segmentation and classification of lung cancer in CT scans, supporting early diagnosis and clinical decision-making.

Breast cancer is a leading cause of death among women globally, and early detection is critical for improving survival rates. This paper introduces an innovative framework that integrates Vision Transformers (ViT) and Graph Neural Networks (GNN) to enhance breast cancer detection using the CBIS-DDSM dataset. Our framework leverages ViT's ability to capture global image features and GNN's strength in modeling structural relationships, achieving an accuracy of 84.2%, outperforming traditional methods. Additionally, interpretable attention heatmaps provide insights into the model's decision-making process, aiding radiologists in clinical settings.

Skin cancer is among the most prevalent and life-threatening diseases worldwide, with early detection being critical to patient outcomes. This work presents a hybrid machine and deep learning-based approach for classifying malignant and benign skin lesions using the SLICE-3D dataset from ISIC 2024, which comprises 401,059 cropped lesion images extracted from 3D Total Body Photography (TBP), emulating non-dermoscopic, smartphone-like conditions. Our method combines vision transformers (EVA02) and our designed convolutional ViT hybrid (EdgeNeXtSAC) to extract robust features, employing a segmentation-assisted classification pipeline to enhance lesion localization. Predictions from these models are fused with a gradient-boosted decision tree (GBDT) ensemble enriched by engineered features and patient-specific relational metrics. To address class imbalance and improve generalization, we augment malignant cases with Stable Diffusion-generated synthetic lesions and apply a diagnosis-informed relabeling strategy to harmonize external datasets into a 3-class format. Using partial AUC (pAUC) above 80 percent true positive rate (TPR) as the evaluation metric, our approach achieves a pAUC of 0.1755 -- the highest among all configurations. These results underscore the potential of hybrid, interpretable AI systems for skin cancer triage in telemedicine and resource-constrained settings.